1,2-distearoylphosphatidylethanolamine and Pancreatic Neoplasms

1,2-distearoylphosphatidylethanolamine has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bridal, SL; Chaminade, P; Díaz-López, R; Fattal, E; Jaillard, D; Libong, D; Marsaud, V; Nicolas, V; Santin, M; Tsapis, N; Vauthier, C	1

Other Studies

1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Pancreatic Neoplasms

Article	Year
The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent. Biomaterials, 2010, Volume: 31, Issue:7 Topics: Animals; Chromatography; Complement Activation; Complement C3; Contrast Media; Electrophoresis, Gel, Two-Dimensional; Fluorocarbons; Humans; Hydrocarbons, Brominated; Hydrophobic and Hydrophilic Interactions; Mice; Nanocapsules; Pancreatic Neoplasms; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Surface Properties; Ultrasonics; Ultrasonography	2010

Article

Year

The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent.

Biomaterials, 2010, Volume: 31, Issue:7

Topics: Animals; Chromatography; Complement Activation; Complement C3; Contrast Media; Electrophoresis, Gel, Two-Dimensional; Fluorocarbons; Humans; Hydrocarbons, Brominated; Hydrophobic and Hydrophilic Interactions; Mice; Nanocapsules; Pancreatic Neoplasms; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Surface Properties; Ultrasonics; Ultrasonography

2010